GARDP

Last updated

The Global Antibiotic Research & Development Partnership (GARDP) is a Swiss not-for-profit global health organization that aims to assist antibiotic drug development to counter the threat of antibiotic resistance. [1] [2] GARDP forms public and private partnerships to develop and ensure access to antibiotic treatments for people who need them.

Contents

It was founded in 2016 by the World Health Organization and the Drugs for Neglected Diseases initiative. [3] [4] [5] GARDP became a Swiss foundation in 2018. [4]

See also

References

  1. ↑ Årdal, Christine; Balasegaram, Manica; Laxminarayan, Ramanan; McAdams, David; Outterson, Kevin; Rex, John H.; Sumpradit, Nithima (May 2020). "Antibiotic development — economic, regulatory and societal challenges" . Nature Reviews Microbiology. 18 (5): 267–274. doi:10.1038/s41579-019-0293-3. ISSN   1740-1534. PMID   31745330.
  2. ↑ "The Global Antibiotic Research and Development Partnership (GARDP)". www.who.int. Retrieved 2024-12-25.
  3. ↑ "Globale Antibiotika Forschungs- und Entwicklungs-Partnerschaft (Global Antibiotic Research and Development Partnership - GARDP) - DLR Gesundheitsforschung". Deutsche Zentrum für Luft und Raumfahrt e.V. - DLR Gesundheitsforschung (in German). Retrieved 2024-12-25.
  4. 1 2 "Lobbyregistereintrag "GARDP Foundation (Global Antibiotic Research and Development Partnership)"". Lobbyregister beim Deutschen Bundestag (in German). Retrieved 2024-12-25.
  5. ↑ Wasan, Himika; Singh, Devendra; Reeta, K. H.; Gupta, Yogendra Kumar (2023-01-09). "Landscape of Push Funding in Antibiotic Research: Current Status and Way Forward". Biology. 12 (1): 101. doi: 10.3390/biology12010101 . PMC   9855914 . PMID   36671792.


Rod of Asclepius2.svg

This article about a medical organization or association is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.